PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day

PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day

PPD Lights Up Headquarters Downtown for 2021 Rare Disease Day

PPD will shine a light on rare diseases – and its commitment to rare disease research – by illuminating its global headquarters



Rare Disease Day takes place on the last day of February because it is a month known for having a “rare” number of days. This annual event serves to raise awareness among the general public and decision-makers about rare diseases and their impact on patients’ lives. On and around this day, patient organizations, health care providers and industry leaders from countries and regions all over the world hold awareness-raising activities. This year, PPD will illuminate the exterior of its worldwide headquarters with Rare Disease Day colors, including green, pink, blue and purple.




Rare Disease Day is just one opportunity for PPD to pause and reflect on why we are passionate about our work in this important area of drug research and dedicated to improving the lives of patients and families living with rare diseases every day. It also allows PPD to help educate the general public, both locally and globally, on rare diseases. For more information on PPD’s commitment to rare disease research, please visit https://www.ppd.com/therapeutic-expertise/rare-diseases.




Friday, Feb. 26, 2021. Illumination begins shortly after dusk and will end at 11:30 p.m.


(Please note: Rare Disease Day officially is observed on Feb. 28, but PPD is illuminating its headquarters on Friday evening.)


Rain Date: Evening hours of Saturday, Feb. 27, 2021




PPD’s worldwide headquarters, downtown Wilmington


929 N. Front St.


Wilmington, NC 28401




Media outlets gathering b-roll of the illumination must remain on public property when filming and/or photographing the building. No interview opportunities, either in-person or virtual, will be offered for this event. Media outlets may choose to use the following quote for their coverage of the event:




PPD is passionate about making a difference in the lives of people living with rare diseases,” said Wendy Buckland, vice president of PPD’s neuroscience global therapeutic unit. “In the pandemic, Rare Disease Day looks different this year, but PPD is committed to raising awareness in this complex space, and our hope is that the building illumination at our worldwide headquarters will reflect our dedication to helping deliver life-changing therapies for patients around the globe. Throughout the pandemic and across the company, PPD has been able to implement the right solutions, such as tele-visits, to make it easier for people to participate in clinical trials for both rare disease and non-rare disease patients, and that is vital in getting new medicines to market.”




For more information on Rare Disease Day, please visit https://rarediseases.org/rare-disease-day.


About PPD

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppd.com.



Ned Glascock


Nadine Maeser